Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin in CRRT Solution
NCT03672149Phase 1Unknown
- Sponsor
- Drexel University
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 1, open-label trial of cefazolin in bacterial infection (3 arms), sponsored by Drexel University. Primary endpoint: Cefazolin serum levels. Status: unknown.
02
Drugs
cefazolin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03672149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03672149.